These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25638050)

  • 1. [What criteria for an ideal antipsychotic treatment?].
    Bordet R
    Encephale; 2015 Feb; 41(1):39-46. PubMed ID: 25638050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurochemical circuitry of schizophrenia.
    Carlsson A
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S10-4. PubMed ID: 16508890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychopharmacologic approaches to schizophrenic psychoses].
    Giacardy-Paty M; Soubrouillard C; Blin O
    Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of schizophrenia: a review.
    Sigmundson HK
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional versus novel antipsychotics: changing concepts and clinical implications.
    Remington G; Chong SA
    J Psychiatry Neurosci; 1999 Nov; 24(5):431-41. PubMed ID: 10586534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroendocrinology and schizophrenia research].
    Müller-Spahn F
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 64():1-96. PubMed ID: 1682802
    [No Abstract]   [Full Text] [Related]  

  • 8. [Schizophrenia and neural transmission: an excess of analogical treatment?].
    Tassin JP
    Encephale; 1996 Oct; 22 Spec No 3():91-8. PubMed ID: 9036015
    [No Abstract]   [Full Text] [Related]  

  • 9. D1 and D2 and D3.
    Healy D
    Br J Psychiatry; 1991 Sep; 159():319-24. PubMed ID: 1683592
    [No Abstract]   [Full Text] [Related]  

  • 10. Towards more effective antipsychotic treatment.
    Kane JM; Freeman HL
    Br J Psychiatry Suppl; 1994 Nov; (25):22-31. PubMed ID: 7865194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transmitter dysfunction in patients with schizophrenia. Significance for cognitive functioning and treatment].
    Glenthøj BY; Mackeprang T; Bille AE; Hemmingsen RP
    Ugeskr Laeger; 1999 Mar; 161(10):1391-8. PubMed ID: 10085745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Negative symptoms: which antipsychotics?].
    Maurel M; Belzeaux R; Adida M; Azorin JM
    Encephale; 2015 Dec; 41(6 Suppl 1):6S32-5. PubMed ID: 26776390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel targets for drugs in schizophrenia.
    Stone JM; Pilowsky LS
    CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):265-72. PubMed ID: 17691983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Schizophrenia: receptors and clinical aspects].
    Azorin JM
    Encephale; 1997 Apr; 23 Spec No 2():17-9. PubMed ID: 9273301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antipsychotic agents and the future.
    Mackay AV
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):51-3. PubMed ID: 2858482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the biology of schizophrenia through the mechanism of action of clozapine.
    Brunello N; Masotto C; Steardo L; Markstein R; Racagni G
    Neuropsychopharmacology; 1995 Nov; 13(3):177-213. PubMed ID: 8602893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of limbic and cortical regions in schizophrenia: focus on dopamine.
    Marchese G; Pani L
    Eur Psychiatry; 2002 Aug; 17 Suppl 4():349s-354s. PubMed ID: 23573604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms.
    Kasper S
    Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S135-41. PubMed ID: 16872809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of new drugs for the treatment of schizophrenia.
    Cookson J
    Br J Hosp Med; 1987 Dec; 38(6):542-8. PubMed ID: 2893648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.